Actively Recruiting
Optimizing the Ocular Surface With Systane COMPLETE Pre- and Post-operatively in Patients With Dry Eye Planning for Cataract Surgery: An Extension Study of Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery
Led by National Taiwan University Hospital · Updated on 2026-04-24
140
Participants Needed
1
Research Sites
144 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Compare the corneal astigmatism data before and after the use of Systane COMPLETE to evaluate its impact on predicting changes in postoperative residual astigmatism, as well as the effects of using or not using Systane COMPLETE on preoperative and postoperative Ocular Surface Disease Index (OSDI) scores and Non-Invasive Tear Break-Up Time (NITBUT).
CONDITIONS
Official Title
Optimizing the Ocular Surface With Systane COMPLETE Pre- and Post-operatively in Patients With Dry Eye Planning for Cataract Surgery: An Extension Study of Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Cataract patients aged 20 to 85 years
- Patients with normal cognitive function able to complete the dry eye questionnaire with assistance from the research team
- Patients willing to undergo phacoemulsification and intraocular lens implantation under topical anesthesia
- Cataract patients who participated in the original Systane COMPLETE trial and did not withdraw midway
You will not qualify if you...
- Patients unwilling to participate in this trial after surgery
- Unable to answer the dry eye questionnaire
- History of ocular trauma or ocular surgery in the planned surgical eye
- Active ocular infection
- Obvious abnormalities in ocular surface or eyelid margins other than meibomian gland dysfunction causing decreased vision other than cataracts
- Presence of corneal abnormalities or epithelial defects as shown by positive corneal fluorescein staining
- Current use of systemic drugs including tetracycline derivatives, antihistamines, or isotretinoin
- Using dry eye medication at screening stage
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Taiwan University Hospital
Taipei, Taiwan, 100
Actively Recruiting
Research Team
C
Chiun Ho Hou, Ph.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here